TDAC
NASDAQ · N/A
Translational Development Ac
$10.69
+0.00 (+0.00%)
Open$10.71
Previous Close$10.69
Day High$10.71
Day Low$10.69
52W High$10.80
52W Low$10.27
Volume—
Avg Volume60.9K
Market Cap283.98M
P/E Ratio45.71
EPS$0.28
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 211.68M | 197.91M | 234.06M |
| Net Income | 7.59M | 7.31M | 8.97M |
| Profit Margin | 3.6% | 3.7% | 3.8% |
| EBITDA | 13.67M | 12.28M | 15.52M |
| Free Cash Flow | 6.88M | 4.06M | 6.97M |
| Rev Growth | +3.0% | +7.4% | -1.8% |
| Debt/Equity | 0.09 | 0.09 | 0.09 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.66 | -0.60% | — | 4.19B |
| PICS | Pics Nv | $10.63 | -0.09% | 6.1 | 1.37B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.40% | 74.6 | 640.19M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.67 | -0.19% | 35.3 | 334.79M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.10% | 57.5 | 591.76M |